Evidence map›Paper›PMID 42882383›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Comparative Immunohistochemical Analysis of FAP and c-MET Expression Across Renal Cell Carcinoma Subtypes: Preliminary Results and Potential Theranostic Implications.

Lena M Unterrainer, Adrien Holzgreve, Sophie C Siegmund, Magdalena Schöll, Julia Schwenke, Rudolf A Werner, Frederick Klauschen, Michael Staehler, Stephan T Ledderose

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lena M UnterrainerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, 91377 Munich, Germany.
Adrien HolzgreveDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, 91377 Munich, Germany.ORCID 0000-0002-9566-8438
Sophie C SiegmundDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, 91377 Munich, Germany.
Magdalena SchöllDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, 91377 Munich, Germany.
Julia SchwenkeInstitute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Rudolf A WernerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, 91377 Munich, Germany.ORCID 0000-0003-3372-6046
Frederick KlauschenInstitute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Michael StaehlerDepartment of Urology, LMU University Hospital, LMU Munich, 81377 Munich, Germany.ORCID 0000-0002-4574-6522
Stephan T LedderoseInstitute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.ORCID 0000-0001-7313-2088

Funding

Ludwig Maximilian University of Munich
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cMETFAPimmunohistochemistryRCCtheranostics

Identifiers

PMID42882383
PMCPMC13663993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.